ロード中...
FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells
Cancer initiating cells (CICs) drive tumor formation and drug-resistance, but how they develop drug-resistance characteristics is not well understood. In this study, we demonstrate that chemotherapeutic agent FOLFOX, commonly used for drug-resistant/metastatic colorectal cancer (CRC) treatment, indu...
保存先:
| 出版年: | Int J Mol Sci |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7828641/ https://ncbi.nlm.nih.gov/pubmed/33451103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22020753 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|